Skip to main content

Advertisement

SpringerLink
Log in

Expression of “Spot 14” (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker

  • Preclinical study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Most breast cancers are “lipogenic”, defined by high fatty acid synthase (FAS) content and dependence on fatty acid synthesis for growth and survival. S14 (Spot 14; THRSP) is a nuclear protein that activates genes required for fatty acid synthesis. The S14 gene is amplified in ~15% of breast cancers, but clinical correlates of its expression were unknown. We analyzed 131 breast cancers by immunohistochemistry for S14 and FAS. Staining was graded 0, 1, or 2+, and scores were correlated with traditional tumor markers, histological features, and outcome. S14 and FAS staining were related to tumor size (p=0.05 for S14, p=0.038 for FAS), but not to stage. S14 but not FAS scores correlated with tumor grade in both DCIS (p=0.003) and invasive cases (p<0.001). Invasive cases (pooled node − and +) with weak S14 staining (n=21) showed no recurrence over 3000 d follow-up, including 10 cases with lymph node involvement, whereas 32% of 67 strongly-staining tumors recurred (log rank p<0.0001). S14 scores did not cosegregate with sex steroid receptors, Her2/neu, or cyclin D1. Low level S14 expression is associated with prolonged disease-free survival in invasive cases, including those with nodal metastasis. High-level expression of S14 identifies a subset of high-risk breast cancers that is not specified by analysis of sex steroid receptors, Her2/neu, or cyclin D1, and provides a molecular correlate to histologic features that predict recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

DCIS:

ductal carcinoma in situ

ER:

estrogen receptor

FAS:

fatty acid synthase

FISH:

fluorescent in situ hybridization

PCR:

polymerase chain reaction

PgR:

progesterone receptor

S14:

spot 14

THRSP:

thyroid hormone-responsive spot 14 protein

References

  1. Cunningham B, Moncur J, Huntington J, Kinlaw WB “Spot 14” protein: a metabolic integrator in normal and neoplastic cells Thyroid 8: 815–825, 1998

    Article  PubMed  CAS  Google Scholar 

  2. Kinlaw W, Church J, Harmon J, Mariash C Direct evidence for a role of the “spot 14” protein in the regulation of lipid synthesis J Biol Chem 270: 16615–16618, 1995

    Article  PubMed  CAS  Google Scholar 

  3. Brown SB, Maloney M, Kinlaw WB “Spot 14” protein functions at the pretranslational level in the regulation of hepatic metabolism by thyroid hormone and glucose J Biol Chem 272: 2163–2166, 1997

    Article  PubMed  CAS  Google Scholar 

  4. Zhu Q, Anderson G, Mucha G, Parks E, Metkowski J, Mariash C The spot 14 protein is required for de novo lipid synthesis in the lactating mammary gland Endocrinol 146: 3343–3350, 2005

    Article  CAS  Google Scholar 

  5. Moncur J, Park J, Mohandes TK, Memoli V, Kinlaw W The “spot 14” gene resides on the telomeric end of the 11q13 amplicon and is expressed in lipogenic breast cancers Proc Natl Acad Sci USA 95: 6989–6994, 1998

    Article  PubMed  CAS  Google Scholar 

  6. Kuhajda F, Piantadosi S, Pasternack G Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease NEJM 321: 636–641, 1989

    PubMed  CAS  Google Scholar 

  7. Kuhajda F Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology Nutrition 16: 202–208, 2000

    Article  PubMed  CAS  Google Scholar 

  8. Pizer E, Wood F, Heine H, Romanstev F, Pasternak G, Kuhajda F Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer Cancer Res 56: 1189–1193, 1996

    PubMed  CAS  Google Scholar 

  9. Pizer E, Jackisch C, Wood F, Pasternak G, Davidson N, Kuhajda F Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells Cancer Res 56: 2745–2747, 1996

    PubMed  CAS  Google Scholar 

  10. Kridel S, Axelrod F, Rozenkrantz N, Smith J Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity Cancer Res 64: 2070–2075, 2004

    Article  PubMed  CAS  Google Scholar 

  11. Hinds P, Dowdy S, Eaton E, Arnold A, Weinberg R Function of a human cyclin gene as an oncogene Proc Natl Acad Sci USA 91: 709–713, 1994

    Article  PubMed  CAS  Google Scholar 

  12. Petty W, Dragnev K, Memoli V, et al. Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers Clin Canc Res 10: 7547–7554, 2004

    Article  CAS  Google Scholar 

  13. Martel P, Bingham C, McGraw C, Baer C, Morganelli P, Meng M, Armstrong J, Moncur J, Kinlaw W S14 protein in breast cancer cells: direct evidence of regulation by SREBP-1c, superinduction with progestin, and implication on cell growth Exp Cell Res 312: 278–288, 2006

    PubMed  CAS  Google Scholar 

  14. Kinlaw WB, Ling NC, Oppenheimer JH Identification of rat S14 protein and comparison of its regulation with that of mRNA S14 employing synthetic peptide antisera J Biol Chem 264: 19779–19783, 1989

    PubMed  CAS  Google Scholar 

  15. Jensen V, Ladekarl M, Holm-Nielsen P, Melsen F, Soerensen F The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer J Pathol 176: 343–352, 1995

    Article  PubMed  CAS  Google Scholar 

  16. Milgraum L, Witters L, Pasternack G, Kuhajda F Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma Clin Canc Res 3: 2115–2120, 1997

    CAS  Google Scholar 

  17. Menard S, Pupa S, Campiglio M, Tagliabue E Biologic and therapeutic role of Her2 in cancer Oncogene 22: 6570–6578, 2003

    Article  PubMed  CAS  Google Scholar 

  18. Schuuring E, Verhoeven E, van Tintern H, et al. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer Cancer Res 52: 5229–5234, 1992

    PubMed  CAS  Google Scholar 

  19. Champeme M, Bieche I, Lizard S, Lidereau R 11q13 amplification in local recurrence of human primary breast cancer Genes, Chromosome Cancer 12: 128–133, 1995

    Article  CAS  Google Scholar 

  20. Alo P, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients Cancer 77: 474–482, 1995

    Article  Google Scholar 

  21. Sanchez-Rodriguez J, Kanininda-Tshilumbu J, Santos A, Perez-Castillo A The spot 14 protein inhibits growth and induces differentiation and cell death of human MCF-7 breast cancer cells Biochem J 392(Pt 1): 57–65, 2005

    Article  PubMed  CAS  Google Scholar 

  22. Heemers H, Vanderhoydonc F, Heyns W, Verhoeven G, Swinnen J Progestins and androgens increase expression of spot 14 in T47-D breast tumor cells Biochem Biophys Res Commun 269: 209–212, 2000

    Article  PubMed  CAS  Google Scholar 

  23. Kumar-Sinha C, Ignatoski K, Lippman M, Ethier S, Chinnaiyan A Transcriptome analysis of Her2 reveals a molecular connection to fatty acid synthesis Cancer Res 63: 132–139, 2003

    PubMed  CAS  Google Scholar 

  24. Moncur J, Park J, Maloney M, Mohandas TK, Kinlaw WB Assignment of the human “spot 14’ gene to 11q13.5 by fluorescence in situ hybridization Cytogen Cell Genet 78: 131–132, 1997

    Article  CAS  Google Scholar 

  25. Dickson C, Fantl V, Gillett C, et al. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer Cancer Lett 90: 43–50, 1995

    Article  PubMed  CAS  Google Scholar 

  26. Gillet C, Fantl V, Bartek J, Dickson C, Barnes D, Peters G Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining Cancer Res 54: 1812–1817, 1994

    PubMed  Google Scholar 

  27. Al-Kuraya K, Schrami P, Torhorst J, Tapia C, Sauter G Prognostic relevance of gene amplifications and coamplifications in breast cancer Cancer Res 64: 8534–8540, 2004

    Article  PubMed  CAS  Google Scholar 

  28. Courjal F, Cuny M, Simony-Lafontaine J, et al. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups Cancer Res 57: 4360–4365, 1997

    PubMed  CAS  Google Scholar 

  29. Michalides R, Hageman P, van Tintern H, et al. A clincopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer British J Cancer 73: 728–734, 1996

    CAS  Google Scholar 

  30. Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G Cyclin D1 and prognosis in human breast cancer Int J Cancer 69: 92–99, 1996

    Article  PubMed  CAS  Google Scholar 

  31. Seshadri R, Lee C, Hui R, McCaul K, Horsfall D, Sutherland R Cyclin D1 amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis Clin Cancer Res 2: 1177–1844, 1996

    PubMed  CAS  Google Scholar 

  32. Chlebowski R, Blackburn G, Elashoff R, et al. Dietary fat reduction in postmenopausal women with primary breast cancer: Phase III Women’s Interventioon Nutrition Study (WINS) Proc Am Soc Clin Oncol 23:3s, 2005

    Google Scholar 

  33. Weiss L, Hoffman G, Schreiber R, et al. Fatty-Acid Biosynthesis in Man, a Pathway of Minor Importance J Biol Chem 367: 905–912, 1986

    CAS  Google Scholar 

  34. Perou C, Jeffrey S, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers Proc Natl Acad Sci USA 96: 9212–9217, 1999

    Article  PubMed  CAS  Google Scholar 

  35. Desai K, Xiao N, Wang W, et al. Initiating oncogenic event determines gene expression patterns of human breast cancer models.Proc Natl Acad Sci USA 99: 6967–6972, 2002

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr. Vincent Memoli for consultation regarding immunohistochemistry, Ms. Maudine Waterman for performing the immunostaining, and Drs. Murray Korc and Mark Schneider for critical readings of the manuscript.

Grant support. NIH RO1 DK 058961 (to W.B.K.), and U.S. Department of Defense grant DAMD17–03-1-0544 (to W.B.K.).

Author information

Authors and Affiliations

  1. Department of Pathology, Dartmouth Medical School, Lebanon, NH, USA

    Wendy A. Wells

  2. Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH, USA

    Wendy A. Wells, Gary N. Schwartz, Peter M. Morganelli, Bernard F. Cole, Jennifer J. Gibson & William B. Kinlaw

  3. Department of Medicine, Dartmouth Medical School, Lebanon, NH, USA

    Gary N. Schwartz & William B. Kinlaw

  4. US Department of Veterans Affairs, VA Hospital, White River Jct., VT, USA

    Peter M. Morganelli

  5. Department of Community and Family Medicine, Dartmouth Medical School, Lebanon, NH, USA

    Bernard F. Cole & Jennifer J. Gibson

  6. Department of Pathology, Division of endocrinology and metabolism, Dartmouth Medical School, 606 Rubin Building, 1 Medical Center Drive, Lebanon, NH, 03756, USA

    William B. Kinlaw

Authors
  1. Wendy A. Wells
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary N. Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter M. Morganelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bernard F. Cole
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jennifer J. Gibson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. William B. Kinlaw
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William B. Kinlaw.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wells, W.A., Schwartz, G.N., Morganelli, P.M. et al. Expression of “Spot 14” (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker. Breast Cancer Res Treat 98, 231–240 (2006). https://doi.org/10.1007/s10549-005-9154-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-9154-z

Keywords

Search

Navigation